2,454 followers
Activation of IGF-1R pathway and NPM-ALK G1269A mutation confer resistance to crizotinib treatment in NPM-ALK positive lymphoma. #lymphoma #lymsm https://t.co/NwOifL3020
Activation of IGF-1R pathway and NPM-ALK G1269A mutation confer resistance to crizotinib treatment in NPM-ALK positive lymphoma. #lymphoma #lymsm https://t.co/NwOifL3020